» Articles » PMID: 31808991

Increasing Insulin Resistance Predicts Adverse Pregnancy Outcomes in Women with Gestational Diabetes Mellitus

Overview
Journal J Diabetes
Specialty Endocrinology
Date 2019 Dec 7
PMID 31808991
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study aimed to investigate the association between maternal insulin resistance (IR) in the late second trimester and pregnancy outcomes, as well as to identify risk factors of IR among women with gestational diabetes mellitus (GDM).

Methods: A retrospective study was conducted among 2647 women diagnosed with GDM. IR was evaluated using the homeostasis model assessment method for IR (HOMA-IR) in the late second trimester (between 24 and 28 weeks), and the lipid profiles were measured at the same time. Patients were divided into groups based on quartiles of HOMA-IR. The information on pregnancy outcomes and risk factors was extracted from the medical records of all participants and entered electronically. Logistic regression models were used to analyze the associations between HOMA-IR and pregnancy outcomes, as well as the associations between risk factors and HOMA-IR.

Results: Greater IR was associated with cesarean delivery, preterm delivery, macrosomia, and large for gestational age newborns, but only significantly associated with preterm delivery after adjustment for potential confounders (P < .001). Prepregnancy body mass index (BMI), weight gain before diagnosis of GDM, and triglycerides were significantly related with IR in the late second trimester (P < .001). Besides, the total area under the curve of the diagnostic 75-g oral glucose tolerance test and glycosylated hemoglobin A1c increased from the lowest to the highest HOMA-IR groups.

Conclusions: Increasing IR in the late second trimester predicts adverse pregnancy outcomes especially for preterm delivery in women with GDM. Additionally, prepregnancy BMI and weight gain before diagnosis of GDM are independent risk factors for the development of IR.

Citing Articles

Circulating miR-486-3p as a potential biomarker for the diagnosis of gestational diabetes mellitus and the prediction of adverse pregnancy outcomes.

Hu Y, Zeng Y, Du X, Li Q, Cao Y, Song H BMC Pregnancy Childbirth. 2025; 25(1):291.

PMID: 40089727 DOI: 10.1186/s12884-025-07405-6.


Association between area under the curve of oral glucose tolerance test and the risk of preterm birth among women with gestational diabetes mellitus: a mediation effect of gestational weight gain.

Liu J, Li H, Wang X, Liu B, He D, Zhang G BMC Pregnancy Childbirth. 2025; 25(1):267.

PMID: 40069626 PMC: 11895138. DOI: 10.1186/s12884-025-07383-9.


An elevated triglyceride-glucose index in the first-trimester predicts adverse pregnancy outcomes: a retrospective cohort study.

Song S, Luo Q, Zhong X, Huang M, Zhu J Arch Gynecol Obstet. 2025; .

PMID: 40009162 DOI: 10.1007/s00404-025-07973-0.


Association between the atherogenic index of plasma and non-alcoholic fatty liver disease in Korean pregnant women: secondary analysis of a prospective cohort study.

Shuai R, He Y, Yang D, Zhang Y, Zhang L Front Nutr. 2025; 12:1511952.

PMID: 39957769 PMC: 11825326. DOI: 10.3389/fnut.2025.1511952.


Evaluation of Maternal Factors Affecting Postpartum Insulin Resistance Markers in Mothers with Gestational Diabetes-A Case-Control Study.

Karcz K, Gawel P, Krolak-Olejnik B Nutrients. 2024; 16(22).

PMID: 39599657 PMC: 11597180. DOI: 10.3390/nu16223871.